{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:36:52Z","timestamp":1792057012344,"version":"4.4.0"},"reference-count":16,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood & Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1002\/pbc.31738","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:08:57Z","timestamp":1745453337000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypersensitivity to Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia and Management With Desensitization"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-8882","authenticated-orcid":false,"given":"Jason","family":"Catanzaro","sequence":"first","affiliation":[{"name":"National Jewish Health  Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van Doorninck","sequence":"additional","affiliation":[{"name":"Rocky Mountain Hospital for Children  Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castells","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital  Boston Massachusetts USA"},{"name":"Dana\u2010Farber Cancer Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"e_1_2_1_6_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1101098"},{"key":"e_1_2_1_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016923"},{"key":"e_1_2_1_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53"},{"key":"e_1_2_1_6_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.138"},{"key":"e_1_2_1_6_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon\u20102021\u20101288"},{"key":"e_1_2_1_6_7_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137380"},{"key":"e_1_2_1_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29169"},{"key":"e_1_2_1_6_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.902117"},{"key":"e_1_2_1_6_10_1","unstructured":"Food and Drug Administration.ONCASPAR\u00ae(Pegaspargase) Prescribing Information.2011 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103411s5126lbl.pdf#:~:text=Oncaspar%C2%AE%20is%20indicated%20as%20a%20component%20of%20a Oncaspar%C2%AE%20is%202%2C500%20Units%2Fm2%20International%20intramuscularly%20or%20intravenously."},{"key":"e_1_2_1_6_11_1","volume-title":"Servier Pharmaceuticals LLC","year":"2023"},{"key":"e_1_2_1_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30891"},{"key":"e_1_2_1_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2019.07.010"},{"key":"e_1_2_1_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002241"},{"key":"e_1_2_1_6_15_1","unstructured":"M.Matherne. \u201cPharmacokinetic Summary and Toxicities of Calaspargase Pegol in Pediatric Patients.\u201d Abstract presented at20th Hematology\/Oncology Pharmacy Association (HOPA) Annual Conference.2024."},{"key":"e_1_2_1_6_16_1","unstructured":"J.Fry E.Guest andK.August. \u201cAn Increased Failure Rate of Asparaginase Desensitization With Calaspargase Pegol.\u201d Abstract presented at theAmerican Society of Pediatric Hematology\/Oncology (ASPHO) Conference.2024."},{"key":"e_1_2_1_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28021"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31738","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.31738","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:50:23Z","timestamp":1775865023000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.31738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/pbc.31738"],"URL":"https:\/\/doi.org\/10.1002\/pbc.31738","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"2025-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e31738"}}